PROSTATE
PROSTATE, licence 80069001: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Idunn Technologies Inc.
- NPN or DIN-HM
- 80069001
- Status
- Active licence
- Licence date
- 29 April 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 50.0 microgrammes | Not calculated |
| Sélénium Source : Oryza sativa - Graine | 50.0 microgrammes | Not calculated |
| Lycopène tout trans Source : Lycopène | 20.0 milligramme | Not calculated |
| Olea europaea Source : Fruit Extraction ratio : 80:1 Dry plant equivalent : 3520 milligramme Potency : 12.0 % 3,4-dihydroxyphényléthanol | 44.0 milligramme | Not calculated |
| Serenoa repens Source : Fruit Extraction ratio : 10:1 Dry plant equivalent : 3000 milligramme Potency : 45.0 % Acides gras | 300.0 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Amidon de maïs, ascorbate de sodium, dl-alpha tocophérol, Maltodextrine, Huile de maïs, farine de riz, Amidon de maïs modifié
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Aide à maintenir la prostate en santé. Utilisé en phytothérapie pour aider à soulager les symptômes urologiques associés à l'hypertrophie bénighe de la prostate, légère à modérée. Fournit des antioxydants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé avant d'en faire l'usage afin d'exclure un diagnostic du cancer de la prostate. Consulter un praticien de soins de santé si les symptômes persistent. Consulter un praticien de soins de santé si les symptômes s'aggravent. Entreposer dans un contenant fermé hermétiquement et photorésistant, dans un endroit frais et sec.
Source
Official Health Canada record, licence 80069001
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.